Los Angeles Capital Management
INBX

Los Angeles Capital Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Los Angeles Capital Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-30,823
Closed -$582K – 1322
2023
Q1 		$582K Sell
30,823
-10,576
-26% -$246K ﹤0.01% 813
2022
Q4 		$1.02M Sell
41,399
-19,631
-32% -$577K 0.01% 703
2022
Q3 		$1.09M Buy
+61,030
New +$1.1M 0.01% 664

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Los Angeles Capital Management's INBX Position: Q2 2023 in Review

Los Angeles Capital Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2023, closing a stake of 30,823 shares — an estimated $582K sold.

Los Angeles Capital Management first reported a position in INBX in Q3 2022 and held it in 3 quarters. The position peaked at $1.09M in Q3 2022. 107 funds tracked by Wall St. Rank hold INBX as of Q2 2023.

  • Los Angeles Capital Management reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Los Angeles Capital Management sold 30,823 Inhibrx, Inc. Common Stock shares in Q2 2023, an estimated $582K.
  • Los Angeles Capital Management first reported a position in Inhibrx, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
  • Los Angeles Capital Management's Inhibrx, Inc. Common Stock position peaked at $1.09M in Q3 2022.
  • 107 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2023.

Based on Los Angeles Capital Management's 13F filing for Q2 2023, filed 3 Aug 2023.